Skip to main content
News Icon

News categories: Honors & Funding

With stem cells against blindness

Prof. Volker Busskamp from the University of Bonn and member of the Cluster of Excellence ImmunoSensation has received a "Proof of Concept Grant" worth 150,000 euros from the European Research Council (ERC).

This funding line is intended to support scientists in transferring their research results from previous ERC projects into commercial applications. Volker Busskamp and his team are working at the Eye Clinic of the University Hospital Bonn on a technology to rapidly program human stem cells to photoreceptor for retinal research and treating blindness in the future.

Volker Busskamp's research focuses on photoreceptors. These are sensory cells of the retina that convert light into electrochemical signals. These stimuli are processed further and enable that seeing. Photoreceptors have special antennae, so-called outer segments, which are very fragile and are the first to degenerate in many eye diseases causing blindness. Busskamp and his team are aiming to protect and restore the structure and function of such photoreceptor cells.

Based on his ERC Starting Grant, which was launched at the Dresden University of Technology in 2016 and funded with 1.5 million euros, Volker Busskamp and his team have succeeded in developing a technology to precisely differentiate human stem cells into photoreceptor cells. Having an unlimited photoreceptor cell source is essential for drug screening, further basic and biomedical research such as photoreceptor replacement therapies.

Contact

Prof. Dr. Volker Busskamp

Eye Clinic at the University Hospital Bonn

Phone: +49-(0)228-28713687

Email: volker.busskamp@uni-bonn.de

Related news

Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry
Honorary Doctorate Sharon Lewin

News categories: Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry

Back to the news overview